Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling
- PMID: 17028262
- DOI: 10.1152/ajplung.00232.2006
Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling
Abstract
Uncontrolled fibroblast activation is one of the hallmarks of fibrotic lung disease. Prostaglandin E(2) (PGE(2)) has been shown to inhibit fibroblast migration, proliferation, collagen deposition, and myofibroblast differentiation in the lung. Understanding the mechanisms for these effects may provide insight into the pathogenesis of fibrotic lung disease. Previous work has focused on commercially available fibroblast cell lines derived from tissue whose precise origin and histopathology are often unknown. Here, we sought to define the mechanism of PGE(2) inhibition in patient-derived fibroblasts from peripheral lung verified to be histologically normal. Fibroblasts were grown from explants of resected lung, and proliferation and collagen I expression was determined following treatment with PGE(2) or modulators of its receptors and downstream signaling components. PGE(2) inhibited fibroblast proliferation by 33% and collagen I expression by 62%. PGE(2) resulted in a 15-fold increase in intracellular cAMP; other cAMP-elevating agents inhibited collagen I in a manner similar to PGE(2). These effects were reproduced by butaprost, a PGE(2) analog selective for the cAMP-coupled E prostanoid (EP) 2 receptor, but not by selective EP3 or EP4 agonists. Fibroblasts expressed both major cAMP effectors, protein kinase A (PKA) and exchange protein activated by cAMP-1 (Epac-1), but only a selective PKA agonist was able to appreciably inhibit collagen I expression. Treatment with okadaic acid, a phosphatase inhibitor, potentiated the effects of PGE(2). Our data indicate that PGE(2) inhibits fibroblast activation in primary lung fibroblasts via binding of EP2 receptor and production of cAMP; inhibition of collagen I proceeds via activation of PKA.
Similar articles
-
Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1.Am J Respir Cell Mol Biol. 2008 Oct;39(4):482-9. doi: 10.1165/rcmb.2008-0080OC. Epub 2008 Apr 17. Am J Respir Cell Mol Biol. 2008. PMID: 18421013 Free PMC article.
-
Role of Epac1 in mediating anti-proliferative effects of prostanoid EP(2) receptors and cAMP in human lung fibroblasts.Naunyn Schmiedebergs Arch Pharmacol. 2008 Dec;378(6):617-30. doi: 10.1007/s00210-008-0334-3. Epub 2008 Jul 22. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18648773
-
Downregulation of protease-activated receptor-1 in human lung fibroblasts is specifically mediated by the prostaglandin E receptor EP2 through cAMP elevation and protein kinase A.FEBS J. 2008 Jul;275(14):3669-79. doi: 10.1111/j.1742-4658.2008.06511.x. FEBS J. 2008. PMID: 18537828
-
[Cooperation of two subtypes of PGE2 receptor, Gi coupled EP3 and Gs coupled EP2 or EP4 subtype].Yakugaku Zasshi. 2003 Oct;123(10):837-43. doi: 10.1248/yakushi.123.837. Yakugaku Zasshi. 2003. PMID: 14577329 Review. Japanese.
-
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment.J Hematol Oncol. 2024 Jan 17;17(1):5. doi: 10.1186/s13045-024-01524-x. J Hematol Oncol. 2024. PMID: 38233872 Free PMC article. Review.
Cited by
-
Asiaticoside might attenuate bleomycin-induced pulmonary fibrosis by activating cAMP and Rap1 signalling pathway assisted by A2AR.J Cell Mol Med. 2020 Jul;24(14):8248-8261. doi: 10.1111/jcmm.15505. Epub 2020 Jun 16. J Cell Mol Med. 2020. PMID: 32548952 Free PMC article.
-
Matrices of physiologic stiffness potently inactivate idiopathic pulmonary fibrosis fibroblasts.Am J Respir Cell Mol Biol. 2013 Apr;48(4):422-30. doi: 10.1165/rcmb.2012-0335OC. Am J Respir Cell Mol Biol. 2013. PMID: 23258227 Free PMC article. Clinical Trial.
-
Age-Associated Increase in Skin Fibroblast-Derived Prostaglandin E2 Contributes to Reduced Collagen Levels in Elderly Human Skin.J Invest Dermatol. 2015 Sep;135(9):2181-2188. doi: 10.1038/jid.2015.157. Epub 2015 Apr 23. J Invest Dermatol. 2015. PMID: 25905589 Free PMC article.
-
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.Sci Transl Med. 2019 Oct 30;11(516):eaau6296. doi: 10.1126/scitranslmed.aau6296. Sci Transl Med. 2019. PMID: 31666402 Free PMC article.
-
Epac Function and cAMP Scaffolds in the Heart and Lung.J Cardiovasc Dev Dis. 2018 Feb 3;5(1):9. doi: 10.3390/jcdd5010009. J Cardiovasc Dev Dis. 2018. PMID: 29401660 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources